30 Results for "

procognitive

" in MedChemExpress (MCE) Product Catalog:
Products (30)

30 Results for "procognitive" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-12700
CAS No.: 1043495-96-0
Purity:  98.75%
RO5256390 is an orally effective trace amine associated receptor 1 (TAAR1) agonist. RO5256390 exhibits pro-cognitive and antidepressant-like properties in rodent and primate models, showing similar brain activation patterns to Olanzapine (HY-14541). RO5256390 blocks compulsive overeating behavior in rats. RO5256390 can inhibit ATP (HY-B2176)-induced TNF secretion in mouse bone marrow-derived macrophages .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101787
CAS No.: 1358575-02-6
Purity:  99.41%
Synonyms: FTBMT
Target:  

GPR52

Research Areas:  

Neurological Disease

TP-024 (FTBMT), a chemical probe, is a selective GPR52 agonist with an EC50 of 75 nM . TP-024 has antipsychotic and procognitive properties .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-120051
CAS No.: 1398496-82-6
Purity:  98.40%
Synonyms: S44819; Egis-13529
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Afizagabar (S44819) is a first-in-class, competitive, and selective antagonist at the GABA-binding site of the α5-GABAAR, with an IC50 of 585 nM for α5β2γ2 and a Ki of 66 nM for α5β3γ2. Afizagabar enhances hippocampal synaptic plasticity and exhibits pro-cognitive efficacy .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-109046
CAS No.: 1038984-31-4
Purity:  99.39%
Synonyms: CX-1632; S-47445
Target:  

iGluR mTOR

Research Areas:  

Neurological Disease

Tulrampator (S-47445) is an orally active selective AMPA receptor modulator. Tulrampator possesses procognitive, enhancing synaptic plasticity, anti-depressant-anxiolytic-like, procognitive and potential neuroprotective properties. Tulrampator can be used for research of alzheimer’s disease and in major depressive disorder .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13058
CAS No.: 851881-60-2
Purity:  99.94%
Target:  

mGluR

Research Areas:  

Neurological Disease

ADX-47273 is a potent, selective and brain-penetrant mGluR5 positive allosteric modulator (PAM), with an EC50 of 0.17 μM for potentiation of glutamate (50 nM) response. ADX-47273 has antipsychotic and procognitive activities .
loading...
    loading...
Cat. No.: HY-171844
CAS No.: 1086377-48-1
Target:  

iGluR

CX1739 is an orally active, blood-brain barrier permeable, low-efficacy AMPA-glutamate receptor (AMPAR) potentiator. CX1739 enhances excitatory neurotransmission by potentiating glutamate-induced excitatory currents and promoting in vivo long-term potentiation. CX1739 eliminates amphetamine-induced locomotor activity, reverses opioid-, pentobarbital- and ethanol-induced respiratory depression, and exerts pro-cognitive effects in animals. CX1739 impairs motor function recovery and increases the risk of post-injury complications. CX1739 can be used in research related to attention-deficit/hyperactivity disorder, dementia, respiratory depression and spinal cord injury .
loading...
    loading...
Cat. No.: HY-107111
CAS No.: 932373-87-0
Purity:  98.78%
Target:  

mAChR

Research Areas:  

Neurological Disease

GSK1034702 is an orally active and allosteric agonist of M1 mAChR (pEC50=8.1) that can cross the blood-brain barrier. GSK1034702 activates the Gq/11 protein-mediated signaling pathway, enhancing neuronal firing and long-term potentiation (LTP) in the CA1 region of the hippocampus. GSK1034702 can modulate hippocampal function, improve memory encoding in the nicotine withdrawal cognitive dysfunction model, and show pro-cognitive effects in rodents. GSK1034702 can be used for the study of the mechanisms of cognitive impairment diseases such as Alzheimer's disease, and has certain peripheral M receptor activation-related side effects (such as gastrointestinal reactions) .
loading...
    loading...
Cat. No.: HY-14826
CAS No.: 166741-91-9
Synonyms: AVE8112
Research Areas:  

Neurological Disease

Tilivapram (AVE8112) is an orally active PDE4 inhibitor with procognitive effects. Tilivapram exhibits in vivo efficacy and improves processing speed and psychomotor speed. Oral administration of tilivapram may induce dose-related adverse reactions such as nausea and dizziness, but transdermal delivery enables slow, controlled elevation of plasma concentrations, thereby significantly reducing gastrointestinal discomfort and dizziness. Tilivapram is applicable to research related to neuropsychiatric disorders .
loading...
    loading...
Cat. No.: HY-109118A
CAS No.: 1791396-46-7
Purity:  99.62%
Synonyms: SUVN-502 mesylate
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Masupirdine mesylate (SUVN-502 mesylate) is a potent, selective, orally active, and brain-penetrating 5-HT6 receptor antagonist (Ki of 2.04 nM for human 5-HT6 receptor). Masupirdine mesylate has pro-cognitive effects on all stages of cognition (acquisition, consolidation, and retention), and can reverse Scopolamine (HY-N0296), MK-801 (HY-15084B)-induced and aging-related memory deficits. Masupirdine mesylate can be used in the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-118363
CAS No.: 1186229-95-7
Target:  

mAChR

Research Areas:  

Neurological Disease

Lu AE51090 is selective muscarinic M1 receptor agonist with blood-brain barrier penetration. Lu AE51090 activates human M1 receptor with EC50 of 61 nM, while showing no significant agonism at M2-M5 receptors. Lu AE51090 exerts procognitive effects in mice. Lu AE51090 can be used for the study of Alzheimer’s disease (AD) and cognitive impairment associated with schizophrenia (CIAS) .
loading...
    loading...
Cat. No.: HY-14827
CAS No.: 170381-16-5
Synonyms: Lu 31-130
Research Areas:  

Neurological Disease

Zicronapine is an antipsychotic agent with a strong pro-cognitive effect in animal models and the potential to treat a number of neurological and psychiatric diseases. Zicronapine has potent antagonistic effects at dopamine D1/D2, and serotonin 5-HT2A receptors .
loading...
    loading...
Cat. No.: HY-14827A
CAS No.: 170381-17-6
Synonyms: Lu 31-130 fumarate
Research Areas:  

Neurological Disease

Zicronapine (Lu 31-130) fumarate is an antipsychotic agent with a strong pro-cognitive effect in animal models and the potential to treat a number of neurological and psychiatric diseases. Zicronapine (Lu 31-130) fumarate has potent antagonistic effects at dopamine D1/D2, and serotonin 5-HT2A receptors .
loading...
    loading...
Cat. No.: HY-109118
CAS No.: 701205-60-9
Synonyms: SUVN-502 free base
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Masupirdine free base (SUVN-502 free base) is a potent, selective, orally active, and brain-penetrating 5-HT6 receptor antagonist (Ki of 2.04 nM for human 5-HT6 receptor). Masupirdine free base has pro-cognitive effects on all stages of cognition (acquisition, consolidation, and retention), and can reverse Scopolamine (HY-N0296), MK-801 (HY-15084B)-induced and aging-related memory deficits. Masupirdine free base can be used in the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-106400
CAS No.: 494861-87-9
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

EGIS 11150 is a adrenergic reporter antagonist that has high affinity for adrenergic α1, α2c, 5-HT2A reporters. EGIS 11150 is an antipsychotic compound with procognitive efficacy .
loading...
    loading...
Cat. No.: HY-169163
hBChE-IN-4 (compound 40) is a potent hCA activator and BChE inhibitor with KA values of 266, 76.9, 918, 893, 98.0 nM for hCA I, hCA II, hCA IV, hCA VB, hCA VII, IC50 values of 72.1, 4.2 nM for eeAChE, eqBChE, respectively. hBChE-IN-4 shows no cytotoxicity. hBChE-IN-4 shows potent procognitive effects. hBChE-IN-4 has the potential for the research of neurodegenerative diseases and other neuropsychiatric disorders .
loading...
    loading...
Cat. No.: HY-115724
CAS No.: 1648745-46-3
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

FPPQ is a dual-acting 5-HT3 (Ki = 0.9 nM) and 5-HT6 (Ki = 3 nM) receptor antagonist with antipsychotic and procognitive properties.
loading...
    loading...
Cat. No.: HY-145862
CAS No.: 2763654-60-8
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT6/5-HT2AR antagonist-1 is a potent dual 5-HT6/5-HT2AR antagonist with Ki values of 11 nM and 39 nM, respectively .
loading...
    loading...
Cat. No.: HY-149776
CAS No.: 2408799-43-7
Target:  

nAChR

Research Areas:  

Neurological Disease

RGH-560 (compound 53) shows highly advanced α7 nAChR positive modulator properties and favorable physicochemical features. RGH-560 has robust procognitive in vivo potential. RGH-560 can be used to study Scopolamine (HY-N0296) -induced amnesia in mice .
loading...
    loading...
Cat. No.: HY-174381
BChE-IN-41 is a highly selective Butyrylcholinesterase (BChE) inhibitor (IC50 =12 nM, Ki = 6.6 nM). BChE-IN-41 has high brain penetration with a brain-to-plasma ratio of 9.0. BChE-IN-41 has pro-cognitive effects on mice with AD-like symptoms induced by Scopolamine (HY-N0296) and Aβ1-42 .
loading...
    loading...
Cat. No.: HY-146077
CAS No.: 2411088-16-7
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-HT6/5-HT2A receptor ligand-2 (compound 42) is a brain-penetrant dual 5-HT6/5-HT2A receptor antagonist, with a Ki of 25 nM and 32 nM, respectively. 5-HT6/5-HT2A receptor ligand-2 shows pro-cognitive properties .
loading...
    loading...